StockNews.com began coverage on shares of Cumberland Pharmaceuticals (NASDAQ:CPIX – Free Report) in a research report sent to investors on Friday morning. The firm issued a hold rating on the specialty pharmaceutical company’s stock.
Cumberland Pharmaceuticals Price Performance
Shares of CPIX stock opened at $2.27 on Friday. The business has a fifty day simple moving average of $1.40 and a 200 day simple moving average of $1.40. The company has a market cap of $31.88 million, a P/E ratio of -2.95 and a beta of 0.30. The company has a quick ratio of 0.99, a current ratio of 1.13 and a debt-to-equity ratio of 0.41. Cumberland Pharmaceuticals has a twelve month low of $1.04 and a twelve month high of $3.05.
About Cumberland Pharmaceuticals
Recommended Stories
- Five stocks we like better than Cumberland Pharmaceuticals
- How Investors Can Find the Best Cheap Dividend Stocks
- XPO Stock Gains Momentum as U.S. Trade Outlook Evolves
- About the Markup Calculator
- CarMax Gets in Gear: Is Now the Time to Buy?
- What Are Treasury Bonds?
- Qubit Combat: 2 Stocks Battle for Quantum Supremacy
Receive News & Ratings for Cumberland Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cumberland Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.